Vaccines

Adults who report having ever been told by a doctor they have a weakened or compromised immune system are more likely than others to say they are worried about serious COVID-19 illness, with many reporting continued mask wearing and other precautions as mask mandates and other pandemic-relate restrictions are lifted.

This analysis examines monkeypox vaccine allocations and jurisdictional requests. It explores jurisdictional request rate (the number of vaccine does requested as a share of the jurisdiction’s allocation from HHS) for JYNNEOS, the preferred vaccine. Overall, while most jurisdictions have requested at least their full supply, some are well below that mark, raising questions about how quickly their at-risk populations can get protected.

This post provides updated estimates the number of people who are not up-to-date on COVID-19 vaccination living in counties designated by the CDC as being “high” or “medium” COVID-19 community levels. These are areas of elevated risk, with relatively high levels of new COVID-19 cases and strained hospital capacity. This analysis finds that the number of those not up to date on COVID-19 vaccination, and the most at risk for severe illness, living in areas of elevated risk has grown since early June 2022.

This brief answers key questions about the U.S. monkeypox outbreak to date and identifies issues that may affect the response going forward.

Most Parents Open to Getting Their Young Child Vaccinated Haven’t Yet Spoken to Their Pediatrician Most parents of young children newly eligible for a COVID-19 vaccine are reluctant to get them vaccinated, including 43% who say they will “definitely not” do so, a new KFF COVID-19 Vaccine Monitor survey finds…

In the wake of the FDA’s emergency use authorization for COVID-19 vaccines for children ages 6 months through 4 years old, many parents remain hesitant to vaccinate their children in this age group, with a slight majority saying they view the vaccine as a bigger risk to their child’s health than getting infected with coronavirus.

Children between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.

KFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight who is receiving the vaccine and whether some groups are facing disparities in vaccination.

With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.

Misinformation and confusion about the COVID-19 vaccines and pregnancy is common among women who are pregnant or planning to become pregnant, with about three in ten saying they believe at least one false statement regarding the COVID-19 vaccines.